太龙药业 (600222.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

39.7x

Market Cap

CNY 4.22B

MomentumView details →

1D Return

−3.70%

YTD Return

+29.18%

RSI (14)

59.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

39.7x

Market Cap

CNY 4.22B

RSI (14)

59.0

MomentumView details →

1D Return

−3.70%

YTD Return

+29.18%

ProfitabilityView details →

Gross Margin

27.87%

Net Margin

3.42%

EBITDA Margin

7.76%

ROE (TTM)

3.80%

ROA (TTM)

1.66%

Asset Turnover

0.49x

GrowthView details →

Revenue YoY

+1.09%

EPS YoY

+99.48%

FCF YoY

—

Revenue CAGR 3Y

−3.58%

EPS CAGR 3Y

+18.40%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.54x

Current Ratio

1.26x

Quick Ratio

0.99x

Div Yield

0.16%

Div Rate

CNY 0.01

Div Growth 1Y

−50.00%

Financials snapshotView financials →

Revenue (TTM)

1.78B

Net Income (TTM)

61.07M

Op. CF (TTM)

−161.45M

Latest newsMore news →

No recent news for 600222.SH.

Similar companies

健民集团600976.SH 方盛制药603998.SH ST中珠600568.SH Indivior Pharmaceuticals IncINDV 联环药业600513.SH 卫信康603676.SH Find similar companies →

Latest newsMore news →

No recent news for 600222.SH.